SWITCH OR ADD PEGYLATED-INTERFERON IN CHRONIC HEPATITIS B PATIENTS ON LONG TERM NUCLEOS(T)IDE THERAPY (SWAP TRIAL)
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms SWAP
- 23 Mar 2016 Elderly patient are also included now in the trial as per ClinicalTrials.gov record.
- 23 Mar 2016 Planned number of patients changed from 310 to 255 as per ClinicalTrials.gov record.
- 23 Mar 2016 Planned End Date changed from 1 Jan 2016 to 1 Dec 2017 as per ClinicalTrials.gov record.